References
- Lacroix M, Abi-Said D, Fourney R, Gokaslan ZL, Shi W, DeMont F, . A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190–198.
- Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 1999;52:371–79.
- Stummer W, Reulen H, Meinel T, Pichlmeier U, Schumacher W, Tonn J, . Extent resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurg 2008;62:564–76.
- Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, . Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;2:239–44.
- Yuile P, Dent O, Cook R, Biggs M, Little N. Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables. J Clin Neurosci 2006;13:747–51.
- Miller CR, Perry A. Glioblastoma: Morphologic and Molecular Genetic Diversity. Arch Pathol Lab Med 2007;131:397–406.
- Mineo JF, Bordron A, Baroncini M, Ramirez C, Maurage CA, Blond S, . Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir 2007;149:245–53.
- Jagger C, Gillies C, Moscone F, Cambois E, Van Oyen H, Nusselder W, . Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis. The Lancet 2008;372:2124–31.
- Wrensch M, Rice T, Miike R, McMillan A, Lamborn KR, Aldape K, . Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro-Oncol 2006;12–26.
- Chang SM, Barker FG II. Marital status, treatment and survival in patients with glioblastoma multiforme. a population-based study. Cancer 2005;104:1975–84.
- Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Fine HA, Black PM, . Sociodemographic indicators and risk of brain tumors. Inter J Epidemiol 2003;32:225–33.
- Salander P, Bergenheim AT, Hamberg K, Henriksson R. Pathways from symptoms to medical care: a descriptive study of symptom development and obstacles to early diagnosis in brain tumors patients. Fam Pract 1999;16:143–8.
- Stupp R, Mason WP, Bent MJ, Weller M, Taphoorn MJB, Belanger K, . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.
- Vertosick FT Jr, Selker RG, Pollack IF, Arena V. The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of “Falied” patients. Neurosurgery 1992;30:897–903.
- Wheeler CJ, Yu JS, Black KL. Cellular immunity in the treatment of brain tumors. Clin Neurosur 2004;51:132–9.
- Puget S, Rutka JT. Malignant brain tumors: two steps forward. Clin Neurosurg 2007;54:4–9.
- Henson JW. Treatment of glioblastoma multiforme. Arch Neurol 2006;63:337–41.
- Salcman M, Scholtz H, Kaplan RS, Kulik S. Long-term survival in patients with malignant astrocytoma. Neurosurgery 1994;34: 213–9.
- Chandler KL, Prados MD, Malec MBA, Wilson CB. Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993;32:716–720.
- Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, . Long-term survival with glioblastoma multiforme.Brain.2007;130:2596–606.
- Curry WT Jr, Carter BS, Barker FG. Racial, ethic, and socioeconomic disparities in patient outcome after craniotomy for tumor in adult patient in the United State, 1988–2004.Neurosurgery2010;66:427–38.